Molecure S.A. (FRA:1B1)
Germany · Delayed Price · Currency is EUR 1.488
-0.006 (-0.40%)
At close: Nov 28, 2025
Molecure Cash Flow Statement
Financials in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | -24.42 | -31.29 | -28.37 | -35.95 | -13.64 | 67.96 | Upgrade |
Depreciation & Amortization | 3.35 | 3.93 | 4.11 | 3.86 | 2.87 | 2.53 | Upgrade |
Other Amortization | 0.19 | 0.13 | 0.11 | 0.08 | 0.05 | 0.05 | Upgrade |
Asset Writedown & Restructuring Costs | -1.83 | -0.24 | -1.39 | 0.05 | -2.63 | -2.36 | Upgrade |
Stock-Based Compensation | 4.04 | 4.04 | - | 0.44 | 2.84 | - | Upgrade |
Other Operating Activities | -5.8 | -2.19 | -3.66 | -7.5 | -1.15 | -1.89 | Upgrade |
Change in Accounts Receivable | -30.24 | -30.34 | 7.65 | 4.53 | -0.63 | -12.39 | Upgrade |
Change in Unearned Revenue | - | -0.03 | 0.01 | -0.32 | -1.99 | 2.33 | Upgrade |
Change in Other Net Operating Assets | 3.39 | -1 | -1.74 | 0.69 | 0.78 | 1.21 | Upgrade |
Operating Cash Flow | -51.39 | -56.99 | -23.29 | -34.13 | -13.5 | 57.44 | Upgrade |
Capital Expenditures | -0.04 | -0.66 | -0.36 | -3.32 | -2.45 | -2.09 | Upgrade |
Sale of Property, Plant & Equipment | 0.22 | 0.2 | 0.02 | 0.05 | 0.01 | 0.03 | Upgrade |
Sale (Purchase) of Intangibles | -17.4 | -23.12 | -33.53 | -6.72 | -16.38 | 10.63 | Upgrade |
Investing Cash Flow | -17.22 | -23.57 | -33.87 | -9.99 | -18.82 | 8.58 | Upgrade |
Long-Term Debt Issued | - | - | 0.58 | 0.27 | 0.73 | - | Upgrade |
Total Debt Issued | -1.56 | - | 0.58 | 0.27 | 0.73 | - | Upgrade |
Long-Term Debt Repaid | - | -0.09 | - | - | - | -1.44 | Upgrade |
Total Debt Repaid | -1.7 | -0.09 | - | - | - | -1.44 | Upgrade |
Net Debt Issued (Repaid) | -3.27 | -0.09 | 0.58 | 0.27 | 0.73 | -1.44 | Upgrade |
Issuance of Common Stock | 60.03 | 29.72 | 49.1 | 0.12 | 4.84 | - | Upgrade |
Other Financing Activities | 5.73 | 5.14 | 5.85 | 7.31 | 8.29 | 21.88 | Upgrade |
Financing Cash Flow | 62.49 | 34.76 | 55.53 | 7.7 | 13.86 | 20.45 | Upgrade |
Miscellaneous Cash Flow Adjustments | -0 | - | - | - | - | - | Upgrade |
Net Cash Flow | -6.12 | -45.8 | -1.63 | -36.42 | -18.46 | 86.46 | Upgrade |
Free Cash Flow | -51.43 | -57.65 | -23.65 | -37.45 | -15.95 | 55.35 | Upgrade |
Free Cash Flow Margin | -878.08% | -1974.78% | -647.54% | -498.43% | -1365.60% | 44.31% | Upgrade |
Free Cash Flow Per Share | -2.23 | -2.85 | -1.41 | -2.67 | -1.14 | 4.07 | Upgrade |
Levered Free Cash Flow | -25.5 | -67.18 | -43.06 | -24.26 | -22.75 | 46.93 | Upgrade |
Unlevered Free Cash Flow | -25.46 | -67.15 | -43 | -24.25 | -22.75 | 46.94 | Upgrade |
Change in Working Capital | -26.85 | -31.37 | 5.92 | 4.9 | -1.84 | -8.85 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.